Definitive Contract 75F40123C00184
- Not listed
- This is a $50,000.00 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to the American College of Medical Toxicology, Inc. (ACMT), a non-profit organization specializing in medical toxicology services and expertise. The contract is for TOXIC REGISTRY LICENSE ACCESS, which likely provides the FDA with access to ACMT's Toxicology Investigators Consortium registry database. This contract is not set aside for any specific business type. ACMT also holds a...
- This contract was awarded by the Food and Drug Administration (FDA) to the American College of Medical Toxicology, Inc. (ACMT), a non-profit organization, to provide online access to the Toxic Registry and support COVID-19 related sub-registries. The contract has a total ceiling value of $5,205,550.00 and was awarded on September 29, 2022, with a final completion date of September 29, 2027. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. ACMT, the...
- This is a Firm Fixed Price delivery order under a contract between the Food and Drug Administration (FDA) and the American College of Medical Toxicology, Inc. (ACMT), a nonprofit organization. The delivery order, valued at $565,000.00, is for the "NEAR REAL-TIME SURVEILLANCE OF STIMULANTS IN THE OVERDOSE CRISIS - DRUG OVERDOSE TOXICO-SURVEILLANCE (DOTS) EXPANSION." This contract supports FDA's efforts to monitor adverse events and medical product safety through ACMT's specialized...
- This is a $522,227.89 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the American College of Emergency Physicians (ACEP), a non-profit organization. The contract is for research on naloxone usage, safety, and efficacy in prehospital environments for conventional and emerging synthetic opioids and other combinations. This contract was awarded under a Broad Agency Announcement (BAA) solicitation from the FDA to support regulatory science and innovation. The contract...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $214,000.00 firm fixed price purchase order to the American College of Medical Toxicology, Inc. (ACMT), a non-profit organization, for an "Agents of Opportunity Course" with a completion date of September 30, 2020. ACMT has previously provided medical toxicology expertise and services to federal agencies through prime and subcontracts. This purchase order supports ACMT's specialized...
- The Department of Health and Human Services Food and Drug Administration awarded a $65,000 firm fixed price delivery order to American College Of Medical Toxicology, Inc. for toxic registry access services. The period of performance is September 22, 2021 with an award date of July 20, 2020. The place of performance will be in Silver Spring, Maryland. No set-aside designation was used for this contract. The prime contractor, American College Of Medical Toxicology, Inc., will provide toxicology...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $990,000 firm fixed price definitive contract to the American College of Medical Toxicology, Inc., doing business as ACMT, to provide toxic registry access services. As the parent company of ACMT, the American College of Medical Toxicology Incorporated will oversee work conducted under the contract. The contract term is from April 24, 2020 through April 19, 2023 and performance will...
- The U.S. Food and Drug Administration (FDA) awarded a $549,175.31 cost no fee definitive contract to the American College of Emergency Physicians (ACEP) to analyze the usage, safety, and efficacy of naloxone in emergency departments and pre-hospital settings during the COVID-19 pandemic. ACEP is a non-profit professional society for emergency physicians that has received multiple previous federal contracts and grants from the Department of Health and Human Services and Centers for Disease...
- This is a delivery order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS), to National Medical Services, Inc. (NMS Labs), a leading provider of clinical and forensic toxicology services. The $69,355.33 firm-fixed-price contract is for neurobiobank tissue toxicology testing services to support NIDA's substance use disorder research programs. This order was issued under an existing $1.5 million indefinite...
- This award is a $111,339.20 firm fixed-price delivery order under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services. The award is for neurobiobank tissue toxicology testing services provided by National Medical Services, Inc. (doing business as NMS Labs), a for-profit organization specializing in clinical and forensic laboratory services. This delivery order will...
This is a definitive contract awarded by the Food and Drug Administration (FDA) to the American College of Medical Toxicology, Inc. (ACMT), a non-profit organization specializing in medical toxicology services. The $2,710,011 contract, with a period of performance ending on September 29, 2026, is for characterizing the clinical use, risks, benefits, and effectiveness of naloxone in reversing opioid overdoses in pre-hospital settings. The contract involves using qualitative and quantitative blood toxicology tests to determine these factors. This contract is not set aside for any particular business type. ACMT holds an Indefinite Delivery Vehicle (IDV) contract with the FDA valued at $16 million, under which it has received multiple task orders, including a $565,000 order for near real-time surveillance of stimulants in the overdose crisis and a $7.9 million order for toxic registry online access and COVID-19 pharmacovigilance support. ACMT's expertise in toxicology data and research services makes it a valuable partner for federal health agencies addressing public health challenges related to drug use, overdoses, and medical product safety.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $867.3k | 8/12/25 | |
| P00001 | Funding Only Action | $846.4k | 8/14/24 | |
| Not listed | Not listed | $996.4k | 9/25/23 |